| |
|
|
|
Ocular Therapeutix Inc.  
|
|
5.6 -0.22 (-0.04%) |
12-10 16:00 |
|
Open: |
5.81 |
Pre close: |
5.82 |
Target:
|
7.13
|
|
High: |
5.9 |
Low: |
5.5 |
Resistance:
|
6.10
6.88
|
|
Volume: |
738,749 |
Market Cap: |
230M |
Support:
|
4.85
4.04
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.77
 |
MACD |
MACD(12,26):
|
0.07 |
|
MA(20): |
5.57 |
Signal(12,26,9): |
0.03  |
|
MA(100): |
6.00 |
Stochastic Oscillator |
%K(14,3):
|
43.30 |
|
MA(250): |
6.08 |
%D(3): |
42.88 |
|
Average Volume(K) |
3-Month: |
49806
|
52-Week |
High:
|
8.28 |
|
10-Days: |
99975 |
Low: |
4.22 |
|
RSI |
RSI(14):
|
49.02 |
Change(%): |
32.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.590 |
Return on Equity (ttm) |
-136.7 |
Shares Out. (M) |
41.10 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-82.7 |
Shares Float (M) |
39.87 |
|
EPS Est. Next Year |
-2.110 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.30 |
|
EPS Est. Next Quarter |
-0.530 |
Qtrly Rev. Growth |
-4.8 |
% Held by Institutions |
76.30 |
|
Forward EPS |
-1.381 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
5.480 |
EBITDA (p.s.) |
0.000 |
P/E |
-3.52 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.02 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-45.96 |
P/S |
3836000000.00 |
|
Operating Margin |
-2637.86 |
Levered Free Cash Flow
(M) |
-25.55 |
P/CF |
-5.01 |
|
|
|
|
|
|
